SCHEMBL7427643

SCHEMBL7427643

CC#CCOc1ccc([S+]([O-])C2(C(=O)OCC)CCN(Cc3ccc(Cl)cc3)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADAM17 P78536 10/20 0.56
▸ HTT P42858 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ MMP13 P45452 8/20 0.48
▸ MMP1 P03956 6/20 0.48
▸ MMP9 P14780 5/20 0.48
▸ KMT2A Q03164 6/20 0.47
▸ MEN1 O00255 5/20 0.47
▸ MMP2 P08253 3/20 0.46
▸ MMP14 P50281 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6266879 0.81 ADAM17 (0.77) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL7360808 0.76 ADAM17 (0.56) ADAM17MMP13MMP1MMP9MMP2
SCHEMBL6265309 0.75 ADAM17 (0.65) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL6265256 0.75 MEN1 (0.71) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL6263838 0.74 ADAM17 (0.77) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL6262677 0.74 ADAM17 (0.79) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL6268249 0.74 ADAM17 (0.66) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL6262910 0.73 ADAM17 (0.79) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL6265700 0.73 ADAM17 (0.83) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL6864846 0.73 ADAM17 (0.79) ADAM17HTTSMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147085-A1 ALKYNYL CONTAINING HYDROXAMIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS / TNF-ALPHA CONVERTING ENZYME (TACE) INHIBITORS American Cyanamid Company (US) 2001-10-24 — — EP disclosed
WO-2000044723-A1 ALKYNYL CONTAINING HYDROXAMIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS/TNF-ALPHA CONVERTING ENZYME (TACE) INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-08-03 — — WO disclosed
Send feedback